This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Crill, C. M. Articles by Helms, R. A. Search for Related Content PubMed PubMed Citation Articles by Crill, C. M. Articles by Helms, R. A. Social Bookmarking                         What's this?

Relative Bioavailability of Carnitine Supplementation in Premature Neonates

Catherine M. Crill, PharmD^*,,,, Michael L. Christensen, PharmD^*,,,, Michael C. Storm, PhD^*, and Richard A. Helms, PharmD^*,,,

^* Departments of Pharmacy and Pediatrics, Center for Pediatric Pharmacokinetics and Therapeutics at the University of Tennessee Health Science Center, Memphis, Tennessee; and Methodist Le Bonheur Healthcare, Memphis, Tennessee

Correspondence: Catherine M. Crill, PharmD, BCPS, BCNSP, 26 South Dunlap, Suite 210, Memphis, TN 38163. Electronic mail may be sent to ccrill{at}utmem.edu.

Background: Carnitine is an important nutrient in the infant diet. We compared total plasma carnitine concentrations in premature neonates supplemented with carnitine via parenteral and enteral nutrition. Methods: This is a post hoc analysis of plasma total carnitine concentrations and carnitine intake in neonates randomized in a previous study to receive 20 mg/kg/d carnitine supplementation over 8 weeks. Neonates received L-carnitine initially via parenteral nutrition (PN). When neonates were fed enterally, oral supplementation of L-carnitine was given in divided doses with each feeding. Results: Sixteen neonates (27 ± 2 weeks gestation; 2.9 ± 1.0 days postnatal age at enrollment; 965.6 ± 279.1 g birth weight) are included. Concentrations were below reference range (31.1–60.5 nmol/mL) at baseline and exceeded reference range from week 1 through the last study period. Concentrations were not different from week 1 (108 ± 49) through weeks 4 (87 ± 34) and 8 (83 ± 31). Carnitine intakes and concentrations were compared in neonates receiving 100% parenteral carnitine at week 1 (n = 6) and 100% enteral carnitine at week 8 (n = 8). Concentrations at week 1 (100.1 ± 27.9) were not different (p = .19) from week 8 (78.6 ± 29.3); an estimate of relative bioavailability was 78.6%. Bioavailability with paired analysis of neonates (n = 5) receiving 100% parenteral carnitine at week 1 and 100% enteral carnitine at week 8 was 83.7% ± 41.2% (30.1%–140.6%). Conclusions: Parenteral and enteral supplementation of 20 mg/kg/d carnitine results in plasma total carnitine concentrations that exceed the reference range. Concentrations are not different between parenteral to enteral supplementation, suggesting that enteral carnitine is well absorbed when given daily in divided doses with enteral feedings.

Journal of Parenteral and Enteral Nutrition, Vol. 30, No. 5, 421-425 (2006)
DOI: 10.1177/0148607106030005421


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. M. Crill and R. A. Helms The Use of Carnitine in Pediatric Nutrition Nutr Clin Pract, April 1, 2007; 22(2): 204 - 213. [Abstract] [Full Text] [PDF]